US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
ETF
ヨーロッパ
EU
Leverage Shares 2x Visa ETP Securities (2VIS) 銘柄情報

Leverage Shares 2x Visa ETP Securities (2VIS)

59.1265

0.00

(0.00%)

終了 6月17日 12:30AM

Leverage Shares 2x Visa ETP Securities (2VIS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

59.1265

( - )

買値

59.1265

売値

59.1265

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

59.1265

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

0 €

発行済株式数

-

配当利回り

PER

-

1 株当たり利益 (EPS)

-

歳入

462.12M

純利益

-53.22k

Leverage Shares Public Limited Company operates as a special purpose vehicle that issues exchange traded securities in the United States, China, Hong Kong, and the United Kingdom. The company was incorporated in 2017 and is based in Dublin, Ireland. Leverage Shares Public Limited Company operates as a special purpose vehicle that issues exchange traded securities in the United States, China, Hong Kong, and the United Kingdom. The company was incorporated in 2017 and is based in Dublin, Ireland.

セクター

-

業界

-

ウェブサイト

leverageshares.com

本社

Dublin, Ireland

設立

2026

Leverage Shares 2x Visa ETP Securities is listed in the sector of the ユーロネクスト with ticker 2VIS. The last closing price for Leverage Shares 2x Visa ... was 59.13 €. Over the last year, Leverage Shares 2x Visa ... shares have traded in a share price range of 0.00 € to 0.00 €.

Leverage Shares 2x Visa ... currently has shares in issue.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
OBAIOur Bond Inc	US$ 1.105 (106.70%)	497.84M
CCTGCCSC Technology International Holdings Ltd	US$ 1.4701 (88.62%)	122.57M
CRVOCervoMed Inc	US$ 4.52 (82.26%)	200.68M
NMRANeumora Therapeutics Inc	US$ 1.55 (69.49%)	28.54M
IVDAIveda Solutions Inc	US$ 0.4887 (54.55%)	367.66M
GDCGD Culture Group Ltd	US$ 0.0291 (-72.31%)	800.46M
CIITTianci International Inc	US$ 0.4425 (-70.10%)	9.9M
MEHAFunctional Brands Inc	US$ 0.0081 (-56.91%)	22.82M
VRXAVeraxa Biotech Ag	US$ 10.50 (-50.61%)	563.05k
SNWVSANUWAVE Health Inc	US$ 8.51 (-41.99%)	1.04M
ADTXAditxt Inc	US$ 0.0104 (-19.38%)	1.07B
GDCGD Culture Group Ltd	US$ 0.0291 (-72.31%)	800.46M
OBAIOur Bond Inc	US$ 1.105 (106.70%)	497.84M
IVDAIveda Solutions Inc	US$ 0.4887 (54.55%)	367.66M
SPCXSpace Exploration Technologies Corporation	US$ 201.80 (4.83%)	322.7M

Ammarmalhas

Ammarmalhas 6分前

At 67 and invested for 10+ years and still holding I must think of; Had I invested this money in an AI share this year I would have tripled my money!! Are we correct in holding on!? What are we really waiting for!? I may be losing faith!

ORCA

I SAW THE NEWS ON $VPLM AFTER MARKET.
I CHECKED OUT THE FIRM THEY BROUGHT IN.
THEY ARE BRINGING IN THE BIG GUNS.AGAINST READ BOLD.I AM INCREASING MY TARGETS AFTER THIS NEWS.
FROM .025 HIGH TO .15 WITHIN 2 YEARS.THE STOCK IS SHIFTING TO A POSITIVE OUT LOOK.IMO.
LAST COU

Steady_T

Steady_T 16分前

And yet your entire post is a personal attack. How strange.Clearly not as you wouldn't understand a shady OTC biotech penny stock with little chance of success. You clearly have too much money tied up in this and seem to only respond with personal attacks. Not pretty, hope it's not your retirement m

MineInvestor01

MineInvestor01 18分前

The June 17 announcement was encouraging to read. DTREF’s magnetic and radiometric surveys in Music Valley confirm it is clearly worthwhile to do more exploration. The elevated thorium signatures and the monazite and xenotime mineralization are positives. More needs to be done, of course. That is al

ducci1

ducci1 21分前

Pivot Calcs: SPX Pivot 7527---R1 7547---S1 7491---SPY Pivot 751---R1 753---S1 748----ES Pivot 7606---R1 7634---S1 7577----VIX Pivot 16.20---R1 16,64---S1 15.97---15 min Bull//Bear R/Line 17.42!------!!LOL!!

MartinLutherKing

MartinLutherKing 37分前

SEii Is Going Nuclear ☢️ With News.. Stay Tuned for life changing news$$$$

Achilles deFlandres

Achilles deFlandres 43分前

IMHO, one major event explicitly impacting the timeline of f2 relisting; IT IS NOT IN THE TOP TEN PRIORITIES, MAYBE NOT TOP 100. And, events all take precedence.

nshi2

Translating the OLED Playbook to EOP
Reliability Challenge Modern OLED Solution Electro-Optic Polymer Equivalent
Moisture/Oxygen Ingress (Damp Heat) Dyadic Thin-Film Encapsulation (TFE / ALD) Atomic layer deposition (ALD) directly over the EOP slot
waveguide; passes 85/85 dam

CelestialSage6

CelestialSage6 44分前

It is unfortunate news that Halozyme eventually gave up the mdase patent.

https://www.thebionews.net/news/articleView.html?idxno=25562

MartinLutherKing

MartinLutherKing 45分前

Keep lying to yourself, we all know your looking for em cheapies.. The pedlar short flippers are out of ammo.. Your out of luck, got to slap the ask

Watts Watt

Watts Watt 51分前

Smart investors would take advantage of sharp price drops and scoop up cheap shares manically. To get Jack, you got to be nimble...nary tremble. Frick stay?

shajandr

shajandr 52分前

IMO, Australia and similarly situated oil consumers should treat this 60-day opening as temporary and they ought to buy and ship as much oil as they can gett their hands on in the next 60 days. These types of oil importers should be willing to pay top Dollar to obtain as much oil as they can handle

Stockman1010101

Stockman1010101 52分前

FNMA & FMCC Stock prices targets:
- 1st Target: $9, met 2026
- 2nd Target: $12, met 2026
- 3rd Target: $16, met 2026
- 4th Target: $20, met 2026
-5th Target: $30, met 2027
- 6th Target: $50, met 2027
- 7th Target: $70, met 2027
- 8th Target: $1

Steady_T

Steady_T 57分前

I wondered when you would resort to personal attacks.

Your arguments are weak and do not stand up to scrutiny.
So time to switch to plan B, attack the poster.

Steady_T

Steady_T 59分前

No I don't and neither do you. That is not the issue. NICE may not decide that the cost that NWBO is willing to accept is worth the result.

That is an unknown. If NICE looks at the data and decides that the survival benefit is not worth the cost then the treatment will not be reimbur

gitreal

gitreal 1時間前

They could lease any of that cat-claw, cholla plagued land in the area....and it would all have the same mineral value. Zero.

Now past midway in June....where's Schappert's report?

dmerc

dmerc 1時間前

ASX currently up 33% , ^.05 @ .20

Investor082

Investor082 1時間前

You must keep averaging down every year and plan for some tax loss selling each year too. Gary is an expert at that.

HyGro

HyGro 1時間前

Clearly not as you wouldn't understand a shady OTC biotech penny stock with little chance of success. You clearly have too much money tied up in this and seem to only respond with personal attacks. Not pretty, hope it's not your retirement money.

gitreal

gitreal 1時間前

the acquisition NBRI has announced

What acquisition? Bendito? You actually think that happened? C'mon man......

HyGro

HyGro 1時間前

Evidently you won't, and you can't deal with it and make personal attacks. Sorry, you evidently have too much money tied up in a shady OTC biotech stock that has little chance of going anywhere. Pretty defensive.

Investor082

Investor082 1時間前

We are looking forward to your record breaking 100X miss this year. Only .08 more to go. Go Gary! ;)

Uncleteddy

Uncleteddy 1時間前

https://www.linkedin.com/posts/hoganlovells_congratulations-to-our-longtime-client-delfin-activity-7472311054522359810-5wmR?utm_source=share&utm_medium=member_ios&rcm=ACoAACDR6B0BMOMVMFAaO8s015TkhTQ8bXv4VuQ

Leverage Shares 2x Visa ...

First Trust Hedged Strat...

Contextvision AB

Therapeutic Solutions (EM)

Blockchain Certified Data Token

Strategy Shares

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。